Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by pseudomonas exotoxin coupled to interleukin-13 and -4

Marko Kornmann, JÖrg Kleeff, Waldemar Debinski, Murray Korc

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: Interleukin (IL)-13 and -4 are malfunctional cytokines that bind to specific cell-surface receptors. The aim of this study was to determine whether pancreatic cancer cells express either receptor, and to assess the growth suppressive effects of chimeric proteins composed of a Pseudomonas exotoxin (PE) A mutant (PE38QQR) fused IL-13 (IL-13·PE38QQR) or IL-4 (IL-4-PE38QQR) in these cells. Materials and Methods: Northern and Western blot analysis were used to analyze the expression of IL-4/-13 recepators and the common γ chain (γ(c)) in pancreatic cancer cell lines. MTT growth assays were carried out to assess the effects of IL-4/-13 and IL-4/-13-PE38QQR on cell growth. Results: All 6 pancreatic cancer cell lines examined expressed IL-13Rα1 and IL-4Rα, one cell line expressed IL-13Rα2, and 5 pancreatic cancer cell lines expressed γ(c). IL-13 (5 nM) significantly enhanced ther growth of 3 cell lines, whereas IL-4 (5 nM) enhanced the growth of 1 cell line. In contrast, IL-13-PE38QQR and IL-4-PE38QQR inhibited the growth of all 6 tested cell lines. There were large variations in the individual sensitivity of the cells, with LD50 values ranging from 100 ng/ml to 5 μg/ml for IL-13-PE38QQR and from 20 ng/ml to 10 μg/ml for IL-4-PE38QQR. IL-13 and -4 antagonized these inhibitory activities in some, but not all, of these cell lines. Conclusions: IL-13 and -4 may act as mitogens toward pancreatic cancer cells by activating IL-4- and IL-13-receptors and IL- 13- and IL-4-coupled toxins may ultimateky have a role in the treatment of pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)125-131
Number of pages7
JournalAnticancer Research
Volume19
Issue number1 A
StatePublished - 1999
Externally publishedYes

Fingerprint

Type II Interleukin-4 Receptors
Exotoxins
Interleukin-13
Pseudomonas
Pancreatic Neoplasms
Interleukin-4
Growth
Cell Line
Interleukins
Interleukin-5
Pseudomonas aeruginosa toxA protein
Lethal Dose 50

Keywords

  • Human pancreatic cancer
  • IL-4/13-pseudomonas exotoxin chimeric protein
  • Interleukin-4/-13

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by pseudomonas exotoxin coupled to interleukin-13 and -4. / Kornmann, Marko; Kleeff, JÖrg; Debinski, Waldemar; Korc, Murray.

In: Anticancer Research, Vol. 19, No. 1 A, 1999, p. 125-131.

Research output: Contribution to journalArticle

Kornmann, Marko ; Kleeff, JÖrg ; Debinski, Waldemar ; Korc, Murray. / Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by pseudomonas exotoxin coupled to interleukin-13 and -4. In: Anticancer Research. 1999 ; Vol. 19, No. 1 A. pp. 125-131.
@article{c6adcf68ec84452b8d8e7ae4939d7bc7,
title = "Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by pseudomonas exotoxin coupled to interleukin-13 and -4",
abstract = "Background: Interleukin (IL)-13 and -4 are malfunctional cytokines that bind to specific cell-surface receptors. The aim of this study was to determine whether pancreatic cancer cells express either receptor, and to assess the growth suppressive effects of chimeric proteins composed of a Pseudomonas exotoxin (PE) A mutant (PE38QQR) fused IL-13 (IL-13·PE38QQR) or IL-4 (IL-4-PE38QQR) in these cells. Materials and Methods: Northern and Western blot analysis were used to analyze the expression of IL-4/-13 recepators and the common γ chain (γ(c)) in pancreatic cancer cell lines. MTT growth assays were carried out to assess the effects of IL-4/-13 and IL-4/-13-PE38QQR on cell growth. Results: All 6 pancreatic cancer cell lines examined expressed IL-13Rα1 and IL-4Rα, one cell line expressed IL-13Rα2, and 5 pancreatic cancer cell lines expressed γ(c). IL-13 (5 nM) significantly enhanced ther growth of 3 cell lines, whereas IL-4 (5 nM) enhanced the growth of 1 cell line. In contrast, IL-13-PE38QQR and IL-4-PE38QQR inhibited the growth of all 6 tested cell lines. There were large variations in the individual sensitivity of the cells, with LD50 values ranging from 100 ng/ml to 5 μg/ml for IL-13-PE38QQR and from 20 ng/ml to 10 μg/ml for IL-4-PE38QQR. IL-13 and -4 antagonized these inhibitory activities in some, but not all, of these cell lines. Conclusions: IL-13 and -4 may act as mitogens toward pancreatic cancer cells by activating IL-4- and IL-13-receptors and IL- 13- and IL-4-coupled toxins may ultimateky have a role in the treatment of pancreatic cancer.",
keywords = "Human pancreatic cancer, IL-4/13-pseudomonas exotoxin chimeric protein, Interleukin-4/-13",
author = "Marko Kornmann and J{\"O}rg Kleeff and Waldemar Debinski and Murray Korc",
year = "1999",
language = "English (US)",
volume = "19",
pages = "125--131",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1 A",

}

TY - JOUR

T1 - Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by pseudomonas exotoxin coupled to interleukin-13 and -4

AU - Kornmann, Marko

AU - Kleeff, JÖrg

AU - Debinski, Waldemar

AU - Korc, Murray

PY - 1999

Y1 - 1999

N2 - Background: Interleukin (IL)-13 and -4 are malfunctional cytokines that bind to specific cell-surface receptors. The aim of this study was to determine whether pancreatic cancer cells express either receptor, and to assess the growth suppressive effects of chimeric proteins composed of a Pseudomonas exotoxin (PE) A mutant (PE38QQR) fused IL-13 (IL-13·PE38QQR) or IL-4 (IL-4-PE38QQR) in these cells. Materials and Methods: Northern and Western blot analysis were used to analyze the expression of IL-4/-13 recepators and the common γ chain (γ(c)) in pancreatic cancer cell lines. MTT growth assays were carried out to assess the effects of IL-4/-13 and IL-4/-13-PE38QQR on cell growth. Results: All 6 pancreatic cancer cell lines examined expressed IL-13Rα1 and IL-4Rα, one cell line expressed IL-13Rα2, and 5 pancreatic cancer cell lines expressed γ(c). IL-13 (5 nM) significantly enhanced ther growth of 3 cell lines, whereas IL-4 (5 nM) enhanced the growth of 1 cell line. In contrast, IL-13-PE38QQR and IL-4-PE38QQR inhibited the growth of all 6 tested cell lines. There were large variations in the individual sensitivity of the cells, with LD50 values ranging from 100 ng/ml to 5 μg/ml for IL-13-PE38QQR and from 20 ng/ml to 10 μg/ml for IL-4-PE38QQR. IL-13 and -4 antagonized these inhibitory activities in some, but not all, of these cell lines. Conclusions: IL-13 and -4 may act as mitogens toward pancreatic cancer cells by activating IL-4- and IL-13-receptors and IL- 13- and IL-4-coupled toxins may ultimateky have a role in the treatment of pancreatic cancer.

AB - Background: Interleukin (IL)-13 and -4 are malfunctional cytokines that bind to specific cell-surface receptors. The aim of this study was to determine whether pancreatic cancer cells express either receptor, and to assess the growth suppressive effects of chimeric proteins composed of a Pseudomonas exotoxin (PE) A mutant (PE38QQR) fused IL-13 (IL-13·PE38QQR) or IL-4 (IL-4-PE38QQR) in these cells. Materials and Methods: Northern and Western blot analysis were used to analyze the expression of IL-4/-13 recepators and the common γ chain (γ(c)) in pancreatic cancer cell lines. MTT growth assays were carried out to assess the effects of IL-4/-13 and IL-4/-13-PE38QQR on cell growth. Results: All 6 pancreatic cancer cell lines examined expressed IL-13Rα1 and IL-4Rα, one cell line expressed IL-13Rα2, and 5 pancreatic cancer cell lines expressed γ(c). IL-13 (5 nM) significantly enhanced ther growth of 3 cell lines, whereas IL-4 (5 nM) enhanced the growth of 1 cell line. In contrast, IL-13-PE38QQR and IL-4-PE38QQR inhibited the growth of all 6 tested cell lines. There were large variations in the individual sensitivity of the cells, with LD50 values ranging from 100 ng/ml to 5 μg/ml for IL-13-PE38QQR and from 20 ng/ml to 10 μg/ml for IL-4-PE38QQR. IL-13 and -4 antagonized these inhibitory activities in some, but not all, of these cell lines. Conclusions: IL-13 and -4 may act as mitogens toward pancreatic cancer cells by activating IL-4- and IL-13-receptors and IL- 13- and IL-4-coupled toxins may ultimateky have a role in the treatment of pancreatic cancer.

KW - Human pancreatic cancer

KW - IL-4/13-pseudomonas exotoxin chimeric protein

KW - Interleukin-4/-13

UR - http://www.scopus.com/inward/record.url?scp=0032897715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032897715&partnerID=8YFLogxK

M3 - Article

C2 - 10226533

AN - SCOPUS:0032897715

VL - 19

SP - 125

EP - 131

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1 A

ER -